Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

The Oat mouse model shows mild retinal degeneration, useful for testing treatments.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The new model improves Alopecia Areata classification accuracy to 93.1%.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

UC-MSCs derived secretome therapy may help treat hair loss safely.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

Droplet microfluidics improves efficiency and control in chemistry, biology, and nanotechnology.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Bacopa procumbens extract may help protect the brain in Parkinson's disease.

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

Infant skin cells may be less capable of repairing UV-induced DNA damage than adult cells.

The study identified key immune cell differences between mild and severe alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

The method could grow hair in lab settings without using animals.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The Annurca apple supplement significantly improved hair growth in people with hair loss.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

3D models and organoids improve liposarcoma research and therapy development.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

A new method improves platelet testing for heart disease patients.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.